Workflow
BOSS ZHIPIN(BZ)
icon
Search documents
BOSS直聘-W(02076.HK):招聘求职供求关系改善 盈利能力持续增长
Ge Long Hui· 2025-08-23 12:00
Core Insights - The company reported a revenue of 2.102 billion yuan for FY2025Q2, representing a year-over-year increase of 9.7%, slightly exceeding previous guidance [1] - Adjusted net profit for FY2025Q2 reached 941 million yuan, marking a year-over-year growth of 30.9% [1] - The company anticipates revenue for FY2025Q3 to be between 2.13 billion and 2.16 billion yuan, indicating a year-over-year growth of 11.4% to 13.0% [1] Financial Performance - The gross margin for FY2025Q2 was 85.37%, an increase of 1.89 percentage points year-over-year [2] - The net profit margin improved to 33.83%, reflecting a year-over-year increase of 12.06 percentage points, while the adjusted net profit margin was 44.75%, up 7.26 percentage points year-over-year [2] - Sales, R&D, and management expense ratios were 19.97%, 19.79%, and 14.79% respectively, with sales and R&D expenses decreasing due to cost control and AI efficiencies [2] Market Trends - The contribution from blue-collar workers and lower-tier markets has increased, with significant growth in revenue from small and medium enterprises [3] - The service industry saw accelerated growth in Q2, while the internet sector showed a notable recovery, with active job postings reaching a new high since 2021 [3] - The company’s AI capabilities are enhancing job matching and candidate support, with daily assistance for thousands of job postings [3] Investment Outlook - The macro recruitment demand is showing signs of recovery, and the company's profitability is expected to continue improving [3] - Projected adjusted net profits for 2025-2027 are 3.53 billion, 3.84 billion, and 4.30 billion yuan, reflecting year-over-year growth rates of 30.2%, 8.8%, and 11.9% respectively [3]
Kanzhun: Staying Bullish On Potential Growth Acceleration And Shareholder Base Expansion
Seeking Alpha· 2025-08-22 19:40
Core Viewpoint - The article highlights a positive outlook on Kanzhun Limited (NASDAQ: BZ) (2076.HK), citing better-than-expected results and guidance, along with a change in the company's cash distribution strategy that may attract more investors [1]. Group 1: Company Overview - Kanzhun Limited is positioned as a stock with promising near-term prospects, driven by its recent performance and strategic changes [1]. Group 2: Investment Strategy - The Asia Value & Moat Stocks research service focuses on identifying value investment opportunities in Asia, particularly in Hong Kong, emphasizing deep value balance sheet bargains and wide moat stocks [2].
招商研究一周回顾(0815-0822)
CMS· 2025-08-22 15:25
Macro Insights - The economic growth rate in August is expected to be supported by exports and consumption policies, despite a significant slowdown in the real estate sector, with a target of 5% annual growth remaining achievable [1][15][12] - The industrial added value in July grew by 5.7% year-on-year, with the manufacturing sector showing resilience, particularly in high-tech products and equipment manufacturing [12][13] - Fixed asset investment growth slowed to 1.6% year-on-year in the first seven months, primarily due to a decline in real estate investment, which fell by 12% [13][14] Strategy Insights - Current channels for resident capital entering the market include increasing financing balances and active personal investor accounts, leading to a positive feedback loop in the market [2] - The "anti-involution" market trend can be analyzed through policy expectations and real-world transmission, indicating a shift from theme-driven to profit-driven market dynamics [2] - The technology and small-cap sectors are expected to continue outperforming as more external funds enter the market [2] Industry Reports - The consumer electronics sector is anticipated to see significant opportunities with the upcoming release of new products, particularly in AI-related applications [8] - The coal mining industry is experiencing a continuous improvement in fundamentals, with the price of thermal coal expected to rise [8] - The healthcare sector, particularly innovative drugs, is projected to maintain a positive outlook due to improved profitability [8]
美股前瞻 | 三大股指期货齐涨 鲍威尔讲话重磅来袭
智通财经网· 2025-08-22 11:22
盘前市场动向 1. 8月22日(周五)美股盘前,美股三大股指期货齐涨。截至发稿,道指期货涨0.33%,标普500指数期货涨0.28%,纳指期货涨 0.22%。 | = US 30 | 44,935.00 | 44,947.00 | 44,676.00 | +149.50 | +0.33% | | --- | --- | --- | --- | --- | --- | | = US 500 | 6,388.00 | 6,389.40 | 6,347.50 | +17.80 | +0.28% | | = US Tech 100 | 23,193.60 | 23,207.30 | 23,006.00 | +51.00 | +0.22% | 2. 截至发稿,德国DAX指数涨0.08%,英国富时100指数涨0.05%,法国CAC40指数涨0.25%,欧洲斯托克50指数涨0.30%。 | 德国DAX30 | 24,311.66 | 24,336.17 | 24,218.26 | +20.34 | +0.08% | | --- | --- | --- | --- | --- | --- | | 器 英国富时100 | 9, ...
招证国际:升BOSS直聘-W(02076)目标价至101港元 需求改善助下半年增长持续
Zhi Tong Cai Jing· 2025-08-22 09:21
Group 1 - The core viewpoint is that BOSS Zhipin (02076, BZ.US) is expected to benefit from a recovery in demand in the second half of 2025, with optimism about its long-term prospects due to increasing online recruitment penetration [1] - The company’s non-GAAP net profit forecasts for fiscal years 2025 and 2026 have been raised by 1% and 2% respectively, reflecting improved profit outlook driven by demand recovery and operational leverage [1] - The target price for BOSS Zhipin's Hong Kong stock has been increased from HKD 86 to HKD 101, and the target price for its US stock has been raised from USD 22 to USD 26, maintaining a buy rating [1] Group 2 - In Q2 of this year, BOSS Zhipin's performance exceeded expectations, with revenue increasing by 10% year-on-year, surpassing forecasts by 1%, and non-GAAP net profit rising by 31%, exceeding expectations by 16%, attributed to ongoing efficiency improvements [1] - The demand trend for the company is expected to continue improving, with accelerated growth anticipated in the second half of 2025, and enhanced business performance driven by AI capabilities [1] - The new shareholder return plan is projected to yield a return of 3.4% over the next 12 months, indicating a positive outlook for shareholder value [1]
研报掘金|中金:上调BOSS直聘目标价至23美元 招聘需求持续改善
Ge Long Hui· 2025-08-22 09:12
Core Viewpoint - BOSS Zhipin's revenue for the second quarter reached 2.1 billion yuan, representing a year-on-year growth of 9.7%, slightly exceeding expectations [1] - The non-GAAP net profit was 946 million yuan, higher than anticipated, primarily due to strong gross margin performance and effective control of sales and R&D expense ratios [1] - The guidance for third-quarter revenue is projected to be between 2.13 billion and 2.16 billion yuan, in line with expectations [1] Financial Projections - The company maintains its revenue forecasts for this year and next year, while increasing its non-GAAP net profit estimates by 8% and 6% to 3.52 billion and 3.75 billion yuan, respectively [1] - The target price for BOSS Zhipin's U.S. stock has been raised by 9.5% to $23, with a maintained "outperform" rating, reflecting improved recruitment demand and better-than-expected expense control [1]
异动盘点0822|名创优品涨超20%,快手-W涨超4%,小鹏涨超10%;科蒂大跌超21%,蔚来美股涨超9%
贝塔投资智库· 2025-08-22 04:00
Group 1: Hong Kong Stocks Performance - Miniso (09896) surged over 20% after reporting a 10% year-on-year increase in adjusted net profit for Q2, with TOP TOY revenue skyrocketing by 87.0% [1] - Li Ning (02331) rose over 6% as it announced a 3.3% year-on-year increase in revenue and declared an interim dividend of HKD 0.3359 per share [1] - Innovent Biologics (02096) increased by over 6% following a 26% year-on-year growth in innovative drug revenue, expanding its commercialized innovative drug portfolio to ten products [1] - Tuhu-W (09690) gained over 10% after reporting a 14.6% year-on-year increase in adjusted net profit while continuing to optimize supply-side costs [1] - Kuaishou-W (01024) rose over 4% with impressive Q2 results and accelerated commercialization [1] - UBTECH (09880) increased over 3% as it led the establishment of two national technical standards for humanoid robots [1] - InnoCare Pharma (02577) saw a rise of over 5% after announcing a partnership with NVIDIA [1] Group 2: Other Notable Performances - China Communications Services (00552) fell over 2% despite a slight 0.18% year-on-year increase in net profit attributable to shareholders, with stable development among its three major clients [2] - Parkson Group (03368) surged nearly 25% after reporting a turnaround to profitability in the first half of the year and proposing an interim dividend of HKD 0.02 per share [2] - Esprit Holdings (00330) jumped over 37% after issuing a profit warning, expecting a net profit of approximately HKD 1 million for the six months ending June 30, 2025 [2] - XPeng Motors (09868) rose over 10% as CEO He Xiaopeng increased his stake by purchasing 3.1 million Class A ordinary shares at an average price of HKD 80.49 per share [2] Group 3: US Market Highlights - Coty (COTY.US) plummeted 21.60% due to weak performance in the US market, retailer destocking, and consumers seeking value, impacting Q4 results [3] - NIO (NIO.US) increased by 9.27% ahead of the launch of its new ES8 product and the start of pre-sales [3] - Huazhu Group (HTHT.US) continued to rise by 2.19% with a 41.3% year-on-year increase in revenue and net profit, benefiting from management franchise and licensing business [3] - Boss Zhipin (BZ.US) rose 6.61% after reporting an over 85% year-on-year increase in net profit for the mid-year and extending its share buyback plan [3] - Youlan Group (YOUL.US) surged 17.13% after announcing plans to acquire four companies to expand its online recruitment and regional market share [3] - Hesai Technology (HSAI.US) increased by 11.00% amid market speculation about a potential IPO in Hong Kong to raise approximately USD 300 million [3] Group 4: Additional US Stock Movements - Miniso (MNSO.US) rose 6.38% after reporting a revenue of CNY 9.39 billion for the first half of the year, a year-on-year increase of 21.1%, with adjusted net profit of CNY 1.28 billion [4] - Walmart (WMT.US) fell 4.49% as Q2 adjusted earnings per share fell short of expectations due to increased insurance claims, legal fees, and restructuring costs [4] - Gilead Sciences (GILD.US) dropped 2.18% after CVS Health decided not to include Gilead's new HIV prevention drug Yeztugo in its business plans [4] - XPeng Motors (XPEV.US) rose 11.68% following the CEO's purchase of 3.1 million Class A ordinary shares [5] - Aegon (AEG.US) increased by 7.64% after reporting a turnaround to profitability in the first half of 2025, primarily driven by growth in its US business [5]
BOSS直聘-W(02076):招聘求职供求关系改善,盈利能力持续增长
GOLDEN SUN SECURITIES· 2025-08-22 01:25
证券研究报告 | 季报点评 gszqdatemark 2025 08 22 年 月 日 BOSS 直聘-W(02076.HK) 招聘求职供求关系改善,盈利能力持续增长 业绩概况:FY2025Q2 实现营收 21.02 亿元(yoy+9.7%),略超此前业绩 指引;经调整净利润 9.41 亿元(yoy+30.9%)。此外,公司预计 2025Q3 将实现营收 21.3~21.6 亿元,同比增长 11.4%~13.0%。2025Q2 宏观招 聘需求持续恢复,招聘求职供求关系改善,有望推动后续季度持续复苏。 用户数量与活跃度维持高位,招聘需求边际回暖。2025Q2 月均 MAU 6360 万(yoy+16.48%,qoq+10.42%),截至 2025Q2 付费企业客户达 650 万 (yoy+10.2%,qoq+1.6%),再创历史新高。2025Q2 面向 B 端的在线 招聘服务营收实现 20.78 亿元(yoy+9.8%),主要受益于付费企业用户 数增长,其中小微企业收入贡献显著,规模小于 20 人的企业收入贡献占 比接近 20%。面向 C 端的以候选人增值服务为主的其他服务业务受益于 用户基础扩大延续增长态势, ...
BOSS直聘(BZ.US)涨逾7% 二季度招聘市场需求呈现回暖趋势
Zhi Tong Cai Jing· 2025-08-21 17:14
Core Insights - BOSS Zhipin (BZ.US) shares rose over 7%, closing at $23.68, following the release of its financial report [1] - In Q2 2025, BOSS Zhipin reported revenue of 2.102 billion yuan, a 9.7% increase compared to the same period in 2024 [1] - The CEO Zhao Peng indicated a recovery trend in the recruitment market and limited impact from external competition on the recruitment business [1] Company Updates - BOSS Zhipin announced the appointment of Chen Xu as the new president, effective August 20, 2025, to optimize governance structure and enhance organizational efficiency [1] - Following this appointment, Chen Xu will no longer serve as Chief Marketing Officer but will continue as an executive director [1]
BOSS直聘(BZ):营利润率创季度新高,下一季度收入展望提速
Guoxin Securities· 2025-08-21 15:06
Investment Rating - The investment rating for the company is "Outperform the Market" [5][18]. Core Insights - The company reported a revenue of 2.102 billion RMB for Q2 2025, representing a year-on-year increase of 9.7%, exceeding management's guidance of 6.9-8.5% [7][18]. - Non-GAAP operating profit reached 881 million RMB, up 33.5% year-on-year, while Non-GAAP net profit attributable to shareholders was 946 million RMB, reflecting an 18.2% increase [7][18]. - The company expects revenue growth of 11.4-13.0% for Q3 2025, with anticipated revenue between 2.13 billion and 2.16 billion RMB [3][17]. Revenue and Profitability - The online recruitment business (B-end) generated 2.078 billion RMB in revenue, a 9.8% increase year-on-year, with the number of paying enterprise clients reaching 6.5 million, up 10.2% [2][9]. - The average ARPU (Average Revenue Per User) for the past 12 months was 1,180 RMB, an increase of 3.4% year-on-year [2][9]. - The company's Non-GAAP operating profit margin reached a record high of 41.9%, up 7.5 percentage points year-on-year, driven by cost reduction and efficiency improvements [2][12]. Future Outlook - The company has announced a cash dividend plan totaling approximately 80 million USD for 2025 and extended its existing share repurchase plan to August 2026, increasing the amount to 250 million USD [3][17]. - Adjusted net profit forecasts for 2025-2027 have been raised to 3.521 billion, 4.408 billion, and 5.488 billion RMB, respectively, with expected growth rates of 30%, 25%, and 25% [18][20].